<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Freiburg_bioware_Project_invivo"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu"><UL><LI class="selected"><A href="/Team:Freiburg_bioware/Project/invivo">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Freiburg_bioware/Project/invivo&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Freiburg_bioware/Project/invivo&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Freiburg_bioware/Project/invivo&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Freiburg_bioware/Project/invivo" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Freiburg bioware/Project/invivo</H1><DIV id="bodyContent"><H3 id="siteSub">From 2009.igem.org</H3><P><TITLE>Artisteer</TITLE></P><DIV id="art-main"><DIV class="art-Sheet"><DIV class="art-Sheet-body"><DIV class="art-nav"><UL class="art-menu"><LI><A href="https://2009.igem.org/Team:Freiburg_bioware"><SPAN class="t">Home</SPAN></A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Team"><SPAN class="t">The Team</SPAN></A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Team">Overview</A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Team/Portraits">Portraits</A></LI></UL><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Project" class="active"><SPAN class="t">The
Project</SPAN></A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Project#Subprojects">Subprojects</A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice"><SPAN class="t">Human
Practice</SPAN></A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Ethics">Ethics</A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Safety">Safety</A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Notebook"><SPAN class="t">Notebook</SPAN></A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><SPAN class="t">Parts</SPAN></A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/cloning1">Basic
Parts</A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/cloning">Composite
Parts</A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Collaboration"><SPAN class="t">Collaboration</SPAN></A></LI><LI><A href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><SPAN class="t">Modeling</SPAN></A></LI></DIV><DIV class="art-contentLayout"><DIV class="art-content"><DIV class="art-Post"><DIV class="art-Post-body"><DIV class="art-Post-inner"><DIV class="art-PostMetadataHeader"><H2 class="art-PostHeaderIcon-wrapper"> <I>in vivo</I> assay</H2></DIV><DIV class="art-PostContent"><TABLE style="text-align: left; width: 627px; height: 261px;" border="0" cellpadding="0" cellspacing="0"><TBODY bgcolor="#e2eff9"><TR align="center"><TD>Fluorescence microscope image of RV308 cells,
electroporated with fluorescein labeled oligonucleotides </TD></TR></TBODY></TABLE><H3>Introduction</H3>
In vivo use of programmable restriction enzymes can provide the
opportunity of genome engineering. Here we develop and test strategies
for the application of our programmable restriction endonuclease.
In our strategy we cotransformed Fok_i and Fok_a constructs fused to
binding domains into a certain bacteria strain leading to the basal
expression of the Fok heterodimers. Transformation of single-stranded
bacteriophage M13 DNA hybridized with modified oligonucleotides enables
the Fok heterodimers to bind the DNA. Inside the cells the phage DNA
should be cut by the dimerized and thereby activated Fok_a should
result in a decreased progeny of phages within the bacterial culture in
comparison to control assays. Two ways of detection were envisioned. A
qPCR should reveal successful cutting of the phage DNA by the lack of
amplified phage DNA. In addition an adjacent phage titer determination
via a blue white screening ressembling phage assay by plating the cells
to IPTG/Xgal plates should lead to a decreased number of plaques in
comparison to the control assays. <TABLE style="text-align: left; width: 322px; height: 436px;" border="0" cellpadding="0" cellspacing="0"><TBODY bgcolor="#e2eff9"><TR align="center"><TD>in vivo scheme</TD></TR></TBODY></TABLE><H3>Methods</H3>
In detail two heterodimeric Fok constructs His-Dig-Split-Fok_a
(BBa_K243036) and His-FluA-Split-Fok_i (BBa_K243010) are encoded by two
different plasmids, plasmid pJS419 with a chloramphenicol and pEx with
an ampicillin resistance. This enables a positive selection of the
bacteria strain XL1 blue cotransformed with both plasmids. Subsequent
to the preparation of electrocompetent cotransformed XL1 blue, the M13
ssDNA hybridized with the modified oligonucleotides were inserted into
these bacteria by electroporation at 1.7 kV. The infected cells were
incubated at 37°C for 0.5 h. At different dilutions the phages
were mixed with 180μl ER2738 cells with an OD600 of about 0.5.
Then they were mixed with 3 ml of 42°C warm top agar and plated
on IPTG/X-Gal plates.
XL1 Blue as well as ER2738 harbour a F-plasmid coding for the
omega-fragment of beta-galactosidase. The M13 phages in turn encodes
the lacking alpha-fragment. Consequently, alpha-complementation can be
detected via a screening for blue plaques. After incubation overnight
at 37°C the infected cells were inspected for blue plaques
formation because of the enzymatic cleavage of X-Gal and production of
the blue dye 5,5'-dibromine-4,4'-dichloride-indigo and plaques can be
seen where the phages lysed the XL1 blue cells. In comparison with
plated bacteria only transformed with M13 ssDNA, M13 ssDNA with other
oligos not modified or infected with entire phages directly the number
of pfu (plaque forming units) should be decreased.
Another possible approach is a qPCR after the insertion and incubation
of the phage DNA hybridized with a modified oligo or pure ssDNA into
the XL1 blue. This quantitative real time polymerase chain reaction
allows to amplify and simultaneously quantify a certain sequence of the
phage DNA. The additional feature of the qPCR is the quantification of
the accumulating DNA happens in real time after each amplification
step. The phage DNA would be extracted by boiling preparation, a method
faster than conventional alkaline lysis minipreps leaving the DNA
somewhat dirtier, but adequate for qPCR. After the qPCR with
appropriate primers, the DNA can be quantified with a fluorescent dye,
intercalating in the double-stranded DNA. The expected result would be
a lower amount of double-stranded phage DNA for our XL1 blue
transformed with DNA and oligo in comparison to the control assay.<H3>Results and Discussion</H3>
Our attempt to plate cotransformated XL1 Blue on IPTG/X-Gal plates
showed several blue plaques for the M13 DNA without hybridized
oligonucleotides. In comparison the M13 DNA hybridized with the
modified oligonucleotide showed no blue plaques, demonstrating that the
binding of the basally expressed heterodimeric Fok constructs triggered
by the labeled guide oligonucleotides and the following cleavage of the
phage DNA was successful and the progeny of the phages and thus
alpha/complementation decreased.<TABLE style="text-align: left; width: 464px; height: 272px;" border="0" cellpadding="0" cellspacing="0"><TBODY bgcolor="#e2eff9"><TR><TD>M13 DNA without (left) and with (right) hybridized
modified oligonucleotide, no plaques formation in presence of modified
oligonucleotide</TD></TR></TBODY></TABLE>
The qPCR assay is still in progress. Expected results have still to be
verified.
</DIV></DIV></DIV></DIV><DIV class="art-Post"><DIV class="art-Post-inner"><DIV class="art-PostContent"><P><SPAN class="art-button-wrapper"> </SPAN></P></DIV></DIV></DIV></DIV></DIV><DIV class="art-Footer"><DIV class="art-Footer-inner"><DIV class="art-Footer-text"><P>contact: <A href="mailto:freigem09@googlemail.com">freigem09@googlemail.com</A></P></DIV></DIV></DIV></DIV></DIV><P class="art-page-footer"><A href="http://www.artisteer.com/">Web Template</A>
created with Artisteer.</P></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2009.igem.org/Team:Freiburg_bioware/Project/invivo">http://2009.igem.org/Team:Freiburg_bioware/Project/invivo</A>&quot;</DIV></DIV></DIV><DIV id="footer-box"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Freiburg_bioware/Project/invivo" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Freiburg_bioware/Project/invivo" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Freiburg_bioware/Project/invivo&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Freiburg_bioware/Project/invivo&amp;oldid=169568" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2009.igem.org:Privacy_policy" title="2009.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2009.igem.org:General_disclaimer" title="2009.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>